Laskin, Debra L
- Rutgers University · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #8,983
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$1.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#8,983
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Laskin, Debra L as a PI. Multi-PI records show the full award amount for context.
- 7R01ES033698-02R01Contact PIHarnessing Inflammatory Macrophages to Thwart Lung Disease Caused by Chronic Ozone ExposureRutgers University · Pharmacology (NIH department code)$551.7Kaward amount
- 5R01ES004738-27R01Contact PIActivated Macrophages and Ozone ToxicityRutgers University · Pharmacology (NIH department code)$551.4Kaward amount
Award organization
Organizations that administered FY2023 awards listing Laskin, Debra L as a PI.
FY2023 award administered by Rutgers University (NJ).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardRutgers University
- 2008$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2008Entered Top 50% NationallyRanked #6199
- 2009$2M Cumulative Funding
- 2012R01 Grant Holder
- 2016$5M Cumulative Funding